Free Trial
OTCMKTS:BLOZF

Cannabix Technologies Q1 2026 Earnings Report

Cannabix Technologies logo
$0.25 -0.02 (-7.74%)
As of 02:05 PM Eastern

Cannabix Technologies EPS Results

Actual EPS
-$0.01
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Cannabix Technologies Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Cannabix Technologies Announcement Details

Quarter
Q1 2026
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Cannabix Technologies Earnings Headlines

Cannabix Technologies Inc. (OTCMKTS:BLOZF) Short Interest Update
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying out up to $1,152 a month to regular investors - no mining stocks, no options, no physical metal required. Chief Income Strategist Tim Plaehn calls it a breakthrough strategy that transforms gold's rally into reliable monthly payouts. The next distribution is just days away.tc pixel
Cannabix Technologies Inc BLOZF
See More Cannabix Technologies Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Cannabix Technologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cannabix Technologies and other key companies, straight to your email.

About Cannabix Technologies

Cannabix Technologies (OTCMKTS:BLOZF) is a Canadian technology company focused on developing breath-testing systems for detecting cannabis and other drugs. Its work is aimed primarily at law-enforcement, workplace-safety and occupational-testing applications, where portable tools may help identify recent drug use through breath samples.

The company’s principal development effort is the Cannabix Marijuana Breathalyzer, a device designed to detect tetrahydrocannabinol (THC), the principal psychoactive compound in cannabis. Cannabix has also researched breath-sample collection systems and analytical technologies, including platforms intended to support the detection of additional substances. The company’s products remain subject to development, testing and potential regulatory or commercial requirements.

Cannabix Technologies is based in Vancouver, British Columbia, and serves an international market opportunity through its focus on drug-impaired-driving enforcement and workplace testing. The company is led by Chief Executive Officer and Director Rav Mlait. Its shares trade in the United States under the symbol BLOZF.

View Cannabix Technologies Profile